Skip to the page

Data / Drug companies / Lannett Company, Inc.

Lannett Company, Inc.: 29 products in the FDA NDC directory, labeler code 62175

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Lannett Company, Inc. (labeler code 62175) lists 29 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 29 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on September 1, 2017.

The request: Watch Lannett Company, Inc. (FDA labeler code 62175): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
62175
Products in commercial distribution
29
Packages
68
Finished drugs by generic name
12
Prescription products
29
Over the counter products
0
Controlled substance products
Schedule II 4, Schedule III 2
Flagged as original packager
26 of 26 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
June 30, 1993
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)2793.1%
Authorized generics (NDA)26.9%

Products by type

TypeProductsShare
Prescription drugs29100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, extended release931%
Tablet, film coated, extended release620.7%
Tablet413.8%
Tablet, delayed release310.3%
Capsule, delayed release310.3%
Capsule, delayed release pellets26.9%
Tablet, chewable26.9%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Esomeprazole Magnesium62175-840Capsule, delayed release pelletsGeneric drugs (ANDA)September 1, 2017
Esomeprazole Magnesium62175-820Capsule, delayed release pelletsGeneric drugs (ANDA)September 1, 2017
Niacin62175-322Tablet, extended releaseGeneric drugs (ANDA)February 16, 2017
Niacin62175-320Tablet, extended releaseGeneric drugs (ANDA)February 16, 2017
Buprenorphine and Naloxone62175-458TabletGeneric drugs (ANDA)September 19, 2016
Buprenorphine and Naloxone62175-452TabletGeneric drugs (ANDA)September 19, 2016
Paroxetine Hydrochloride62175-472Tablet, film coated, extended releaseGeneric drugs (ANDA)October 31, 2014
Paroxetine Hydrochloride62175-471Tablet, film coated, extended releaseGeneric drugs (ANDA)October 31, 2014
Paroxetine Hydrochloride62175-470Tablet, film coated, extended releaseGeneric drugs (ANDA)October 31, 2014
Rabeprazole Sodium62175-302Tablet, delayed releaseGeneric drugs (ANDA)November 8, 2013
Methylphenidate Hydrochloride62175-313Tablet, extended releaseGeneric drugs (ANDA)September 23, 2013
Methylphenidate Hydrochloride62175-312Tablet, extended releaseGeneric drugs (ANDA)September 23, 2013
Methylphenidate Hydrochloride62175-311Tablet, extended releaseGeneric drugs (ANDA)July 10, 2013
Methylphenidate Hydrochloride62175-310Tablet, extended releaseGeneric drugs (ANDA)July 10, 2013
Montelukast Sodium62175-205Tablet, chewableGeneric drugs (ANDA)August 3, 2012
Montelukast Sodium62175-204Tablet, chewableGeneric drugs (ANDA)August 3, 2012
Pantoprazole Sodium62175-618Tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Pantoprazole Sodium62175-617Tablet, delayed releaseGeneric drugs (ANDA)January 20, 2011
Oxybutynin Chloride Extended Release62175-272Tablet, extended releaseGeneric drugs (ANDA)March 1, 2009
Oxybutynin Chloride Extended Release62175-271Tablet, extended releaseGeneric drugs (ANDA)March 1, 2009
Oxybutynin Chloride Extended Release62175-270Tablet, extended releaseGeneric drugs (ANDA)March 1, 2009
Omeprazole62175-136Capsule, delayed releaseGeneric drugs (ANDA)January 23, 2009
Nifedipine62175-262Tablet, film coated, extended releaseGeneric drugs (ANDA)October 3, 2007
Nifedipine62175-261Tablet, film coated, extended releaseGeneric drugs (ANDA)November 21, 2005
Nifedipine62175-260Tablet, film coated, extended releaseGeneric drugs (ANDA)November 21, 2005

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.